Cutaneous venous malformations as a clue for possible gastrointestinal tract involvement: Diagnosis and treatment of six cases.
ISSVA
gastrointestinal tract
skin
vascular anomalies
venous malformations
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
revised:
23
02
2021
received:
15
07
2020
accepted:
07
03
2021
pubmed:
23
3
2021
medline:
1
7
2021
entrez:
22
3
2021
Statut:
ppublish
Résumé
Venous malformation (VM) is the most common type among vascular malformations classified by the International Society for the Study of Vascular Anomalies. Most VMs are sporadic (94%), caused in 40% of cases by somatic mutation of TEK gene. VMs can be cutaneous, visceral, or combined. Visceral involvement is rare, and gastrointestinal (GI) tract is the most common localization. Visceral VMs, usually asymptomatic, may manifest with bleeding, anemia, and consumptive coagulopathy, which sometimes require an emergency treatment. Our aim is to study the possible GI involvement in patients with only one cutaneous VM. We analyzed a series of six patients who presented with a single cutaneous VM and have subsequently manifested intestinal involvement at our reference center for vascular anomalies since 2010. In our patients, cutaneous VMs were located on lower or upper limbs, and GI involvement manifested from 3 to 10 years after skin diagnosis. Our experience urges to early diagnose a GI involvement also in patients with only one skin VM and to prevent severe complications. A multidisciplinary approach is mandatory for the diagnosis and treatment of these patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14932Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
ISSVA Classification of Vascular Anomalies ©2018 International Society for the Study of Vascular Anomalies. Available at “issva.org/classification” Accessed [date]: 2020
Wassef M, Blei F, Adams D, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136:e203-e214.
Behravesh S, Yakes W, Gupta N, et al. Venous malformations: clinical diagnosis and treatment. Cardiovasc Diagn Ther. 2016;6:557-569.
Romo Muñoz MI, Bueno A, De La Torre C, et al. Surgical emergencies in intestinal venous malformations. Eur J Pediatr Surg. 2018;28(1):101-104.
Hage AN, Chick JFB, Srinivasa RN, et al. Treatment of venous malformations: the data, where we are, and how it is done. Tech Vasc Interv Radiol. 2018;21(2):45-54.[Review].
Hung JWS, Leung MWY, Liu CSW, et al. Venous malformation and localized intravascular coagulopathy in children. Eur J Pediatr Surg. 2017;27:181-184.
Nakano TA, Zeinati C. Venous thromboembolism in pediatric vascular anomalies. Front Pediatr. 2017;5:158.
Limaye N, Wouters V, Uebelhoer M, et al. Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations. Nat Genet. 2009;41:118-124.
Tang X, Gao J, Yang X, Guo X. A 10-year delayed diagnosis of blue rubber bleb nevus syndrome characterized by refractory iron-deficiency anemia: a case report and literature review. Medicine (Baltimore). 2018;97(22):e10873 [Review].
Boon LM, Vikkula M. Multiple Cutaneous and Mucosal Venous Malformations. 2008 Sep 18 [Updated 2018 May 17]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1967/
Wouters V, Limaye N, Uebelhoer M, et al. Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects. Eur J Hum Genet. 2010;18:414-420.
Boon LM, Mulliken JB, Enjolras O, Vikkula M. Glomuvenous malformation (glomangioma) and venous malformation: distinct clinicopathologic and genetic entities. Arch Dermatol. 2004;140:971-976.
Soblet J, Kangas J, Nätynki M, et al. Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations. J Invest Dermatol. 2017;137(1):207-216.
Fox VL. New therapies for vascular anomalies of the gastrointestinal tract. Minerva Pediatr. 2018;70(3):303-307.
Dasgupta R, Fishman SJ. Management of visceral vascular anomalies. Semin Pediatr Surg. 2014;23(4):216-220.
Barlas A, Avsar E, Bozbas A, Yegen C. Role of capsule endoscopy in blue rubber bleb nevus syndrome. Can J Surg. 2008;51:E119-E120.
Isoldi S, Belsha D, Yeop I, et al. Diagnosis and management of children with blue rubber bleb nevus syndrome: a multi-center case series. Dig Liver Dis. 2019;51(11):1537-1546.
Wong XL, Phan K, Rodríguez Bandera AI, Sebaratnam DF. Sirolimus in blue rubber bleb naevus syndrome: a systematic review. J Paediatr Child Health. 2019;55(2):152-155.
Yuksekkaya H, Ozbek O, Keser M, Toy H. Blue rubber bleb nevus syndrome: successful treatment with sirolimus. Pediatrics. 2012;129(4):e1080-e1084.
Vavricka SR, Heinrich H, Buetikofer S, et al. The Vampire Study: significant elevation of faecal calprotectin in healthy volunteers after 300 ml blood ingestion mimicking upper gastrointestinal bleeding. United European Gastroenterol J. 2018;6(7):1007-1014.